Loading insider details...
Latest Form 4 (Jun 11, 2026): Disposition to Issuer of 100,000 KALV shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Disposition to Issuer | 100,000 | n/a |
| Jan 21, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/Award | 49,000 | n/a |
| Oct 8, 2025 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/Award | 100,000 | n/a |
| Aug 7, 2025 | Sarepta Therapeutics, Inc. (SRPT) | Grant/Award | 6,250 | n/a |
| Mar 12, 2025 | Sarepta Therapeutics, Inc. (SRPT) | Tax Withholding | 523 | $52.4K |
| Mar 11, 2025 | Sarepta Therapeutics, Inc. (SRPT) | Exercise/Conversion | 17,500 | n/a |
| Mar 7, 2025 | Sarepta Therapeutics, Inc. (SRPT) | Tax Withholding | 281 | $28.5K |
| Mar 5, 2025 | Sarepta Therapeutics, Inc. (SRPT) | Tax Withholding | 719 | $74.6K |
| Feb 14, 2025 | Sarepta Therapeutics, Inc. (SRPT) | Grant/Award | 3,500 | n/a |
| Jun 26, 2024 | Sarepta Therapeutics, Inc. (SRPT) | Exercise/Conversion | 6,250 | n/a |